Cite
HARVARD Citation
Lu, F. et al. (2020). Liver Cancer–Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma. Clinical and translational gastroenterology. 11 (12), pp. e00271-. [Online].